Arch Therapeutics, Inc.·4

Jan 23, 12:44 PM ET

Arch Therapeutics, Inc. 4

4 · Arch Therapeutics, Inc. · Filed Jan 23, 2015

Insider Transaction Report

Form 4
Period: 2015-01-22
DAVIS RICHARD E
CFO & TREASURER
Transactions
  • Award

    Stock Option (right to buy)

    2015-01-22+500,000500,000 total
    Exercise: $0.19Exp: 2025-01-21COMMON STOCK (500,000 underlying)
Footnotes (1)
  • [F1]Of the Shares subject to the Option, 25% shall vest immediately, 25% shall vest twelve (12) months after the Vesting Commencement Date, and 1/24 of the remaining unvested Shares subject to the Option shall vest on each of the next twenty four (24) monthly anniversaries of the Vesting Commencement Date thereafter.

Documents

1 file
  • 4
    v399359_4.xmlPrimary

    OWNERSHIP DOCUMENT